Summary
The company was incorporated as Tarsons Products Private Limited on 05 July 1983. The Company was subsequently converted into a public limited company pursuant to a special resolution passed by the Shareholders at the extraordinary general meeting held on 10 May 2021, and the name of the Company was changed to Tarsons Products Limited on 14 June 2021.The Company is engaged in manufacturing and selling of plastic laboratory products and certain scientific instruments.The products find usage in laboratories engaged in research on molecular biology,cell culture,geonomics,proteonomics,immunology etc.The Company caters to both domestic and international markets.The Company has one subsidiary company named Inlabro Pte. Ltd. establised in Republic of Singapore.During the FY2020,the company has converted 2200000 CCDs of Rs 100 each into 8013 class B equity shares of Rs 10 each at a premium of Rs 27444 per share. Pursuant to a resolution passed by the Board on 14 June 2021 and a resolution passed by the Shareholders in the EGM held on 16 June 2021, the Company has sub-divided its face value of equity shares from Rs 10 to Rs 2 each.On 26 June 2021,the company has allotted 49979280 bonus equity shares of Rs 2 each to the shareholders in the ratio of 52:1.During the month of November 2021,the company came out with an Rs 1023.47 crore public issue that comprised of fresh issue of Rs 149.63 crore and an offer for sale of Rs 873.84 crore by promoters and investor.The IPO shares were... Read More
Reports by Tarsons Products Ltd
Reports by Tarsons Products Ltd
